Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus
NCT03961828
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Beta-Thalassemia
Hepatitis C
Interventions
DRUG:
Ledipasvir 90 MG / Sofosbuvir 400 MG [Harvoni]
Sponsor
Tanta University